{"schema_version":"alpha-company-profile-public-v2","slug":"ascentage-pharma-group-international","canonical_url":"https://registry.alpha.ac/companies/ascentage-pharma-group-international","published_on":"2026-09-18T04:45:57.425698+00:00","last_reviewed_on":"2026-09-18T04:45:57.425698+00:00","identity":{"legal_name":"ASCENTAGE PHARMA GROUP INTERNATIONAL","display_name":"ASCENTAGE PHARMA GROUP INTERNATIONAL","headline":"Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development.","description":"Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical conditions, including various cancers, chronic hepatitis B virus (HBV) infections, and age-related ailments. A cornerstone of its product pipeline is HQP1351, a BCR-ABL inhibitor specifically designed to address BCR-ABL1 mutants, notably those carrying the T315I muta","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0002023311","logo":"https://cdn.brandfetch.io/ticker/aapg/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/aapg/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"ASCENTAGE PHARMA GROUP INTERNATIONAL logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-18T04:45:57.425698+00:00"},"security_listings":[{"ticker":"AAPG","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"ASCENTAGE PHARMA GROUP INTERNATIONAL","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"},{"label":"Sector","value":"Healthcare","source_id":"alpha-canonical-company-record"},{"label":"Industry","value":"Biotechnology","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/ascentage-pharma-group-international","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-18T04:45:57.425698+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":18,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":2,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":18,"corroborated_claims":0,"sources":2,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-18T04:45:57.425698+00:00","observed_at":"2026-09-18T04:45:57.425698+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"ascentage-pharma-group-international","canonical_url":"https://registry.alpha.ac/companies/ascentage-pharma-group-international"},"publication":{"published_at":"2026-09-18T04:45:57.425698+00:00","last_reviewed_at":"2026-09-18T04:45:57.425698+00:00","as_of":"2026-09-18T04:45:57.425698+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/ascentage-pharma-group-international","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/ascentage-pharma-group-international","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/ascentage-pharma-group-international.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"ascentage-pharma-group-international","canonical_url":"https://registry.alpha.ac/companies/ascentage-pharma-group-international","as_of":"2026-09-18T04:45:57.425698+00:00","last_reviewed_at":"2026-09-18T04:45:57.425698+00:00","identity":{"legal_name":"ASCENTAGE PHARMA GROUP INTERNATIONAL","display_name":"ASCENTAGE PHARMA GROUP INTERNATIONAL","description":"Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical conditions, including various cancers, chronic hepatitis B virus (HBV) infections, and age-related ailments. A cornerstone of its product pipeline is HQP1351, a BCR-ABL inhibitor specifically designed to address BCR-ABL1 mutants, notably those carrying the T315I muta","jurisdiction":null,"country":"US","sector":"Healthcare","industry":"Biotechnology","website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0002023311","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"AAPG","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"8ff5795f-16ce-460b-8f76-5bcc9555a314","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-18","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"dajun-yang-m-d-ph-d","display_name":"Dajun Yang, M.D., Ph.D.","role_category":"director","title":"Chairman, Chief Executive Officer and Director","committee":null,"is_board_chair":true,"is_independent":false,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"changqing-ye","display_name":"Changqing Ye","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"david-sidransky-m-d-ascentage-pharma-group-international","display_name":"David Sidransky, M.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"debra-yu","display_name":"Debra Yu","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"marc-e-lippman-m-d","display_name":"Marc E. Lippman, M.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"marina-s-bozilenko","display_name":"Marina S. Bozilenko","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"shaomeng-wang-ph-d","display_name":"Shaomeng Wang, Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"simon-dazhong-lu-ph-d","display_name":"Simon Dazhong Lu, Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"wei-ren","display_name":"Wei Ren","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null}],"executives":[{"person_slug":"dajun-yang-m-d-ph-d","display_name":"Dajun Yang, M.D., Ph.D.","role_category":"executive","title":"Chairman, Chief Executive Officer and Director","committee":null,"is_board_chair":true,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"thomas-j-knapp","display_name":"Thomas J. Knapp","role_category":"executive","title":"SVP, General Counsel","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"veet-misra-ph-d","display_name":"Veet Misra, Ph.D.","role_category":"executive","title":"Chief Financial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null},{"person_slug":"yifan-zhai-m-d-ph-d","display_name":"Yifan Zhai, M.D., Ph.D.","role_category":"executive","title":"Chief Medical Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001213900-26-049412","source_url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm","source_type":"sec_20f","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-05T21:39:28.883651+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/ascentage-pharma-group-international#profile","url":"https://registry.alpha.ac/companies/ascentage-pharma-group-international","dateModified":"2026-09-18T04:45:57.425698+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/ascentage-pharma-group-international#organization","legalName":"ASCENTAGE PHARMA GROUP INTERNATIONAL","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL","description":"Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical conditions, including various cancers, chronic hepatitis B virus (HBV) infections, and age-related ailments. A cornerstone of its product pipeline is HQP1351, a BCR-ABL inhibitor specifically designed to address BCR-ABL1 mutants, notably those carrying the T315I muta","url":"https://registry.alpha.ac/companies/ascentage-pharma-group-international","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Chairman, Chief Executive Officer and Director","member":{"@type":"Person","name":"Dajun Yang, M.D., Ph.D.","url":"https://registry.alpha.ac/people/dajun-yang-m-d-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Changqing Ye","url":"https://registry.alpha.ac/people/changqing-ye"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"David Sidransky, M.D.","url":"https://registry.alpha.ac/people/david-sidransky-m-d-ascentage-pharma-group-international"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Debra Yu","url":"https://registry.alpha.ac/people/debra-yu"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Marc E. Lippman, M.D.","url":"https://registry.alpha.ac/people/marc-e-lippman-m-d"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Marina S. Bozilenko","url":"https://registry.alpha.ac/people/marina-s-bozilenko"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Shaomeng Wang, Ph.D.","url":"https://registry.alpha.ac/people/shaomeng-wang-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Simon Dazhong Lu, Ph.D.","url":"https://registry.alpha.ac/people/simon-dazhong-lu-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Wei Ren","url":"https://registry.alpha.ac/people/wei-ren"}},{"@type":"OrganizationRole","roleName":"Chairman, Chief Executive Officer and Director","member":{"@type":"Person","name":"Dajun Yang, M.D., Ph.D.","url":"https://registry.alpha.ac/people/dajun-yang-m-d-ph-d"}},{"@type":"OrganizationRole","roleName":"SVP, General Counsel","member":{"@type":"Person","name":"Thomas J. Knapp","url":"https://registry.alpha.ac/people/thomas-j-knapp"}},{"@type":"OrganizationRole","roleName":"Chief Financial Officer","member":{"@type":"Person","name":"Veet Misra, Ph.D.","url":"https://registry.alpha.ac/people/veet-misra-ph-d"}},{"@type":"OrganizationRole","roleName":"Chief Medical Officer","member":{"@type":"Person","name":"Yifan Zhai, M.D., Ph.D.","url":"https://registry.alpha.ac/people/yifan-zhai-m-d-ph-d"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/ascentage-pharma-group-international"},"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"}},"canonical_source":"aegis_canonical"}